203 related articles for article (PubMed ID: 22282457)
1. Dopaminergic function in the psychosis spectrum: an [18F]-DOPA imaging study in healthy individuals with auditory hallucinations.
Howes OD; Shotbolt P; Bloomfield M; Daalman K; Demjaha A; Diederen KM; Ibrahim K; Kim E; McGuire P; Kahn RS; Sommer IE
Schizophr Bull; 2013 Jul; 39(4):807-14. PubMed ID: 22282457
[TBL] [Abstract][Full Text] [Related]
2. A Test of the Transdiagnostic Dopamine Hypothesis of Psychosis Using Positron Emission Tomographic Imaging in Bipolar Affective Disorder and Schizophrenia.
Jauhar S; Nour MM; Veronese M; Rogdaki M; Bonoldi I; Azis M; Turkheimer F; McGuire P; Young AH; Howes OD
JAMA Psychiatry; 2017 Dec; 74(12):1206-1213. PubMed ID: 29049482
[TBL] [Abstract][Full Text] [Related]
3. Dopamine synthesis capacity before onset of psychosis: a prospective [18F]-DOPA PET imaging study.
Howes OD; Bose SK; Turkheimer F; Valli I; Egerton A; Valmaggia LR; Murray RM; McGuire P
Am J Psychiatry; 2011 Dec; 168(12):1311-7. PubMed ID: 21768612
[TBL] [Abstract][Full Text] [Related]
4. The Effects of Antipsychotic Treatment on Presynaptic Dopamine Synthesis Capacity in First-Episode Psychosis: A Positron Emission Tomography Study.
Jauhar S; Veronese M; Nour MM; Rogdaki M; Hathway P; Natesan S; Turkheimer F; Stone J; Egerton A; McGuire P; Kapur S; Howes OD
Biol Psychiatry; 2019 Jan; 85(1):79-87. PubMed ID: 30122287
[TBL] [Abstract][Full Text] [Related]
5. Midbrain dopamine function in schizophrenia and depression: a post-mortem and positron emission tomographic imaging study.
Howes OD; Williams M; Ibrahim K; Leung G; Egerton A; McGuire PK; Turkheimer F
Brain; 2013 Nov; 136(Pt 11):3242-51. PubMed ID: 24097339
[TBL] [Abstract][Full Text] [Related]
6. Reduced striatal dopamine synthesis capacity in patients with schizophrenia during remission of positive symptoms.
Avram M; Brandl F; Cabello J; Leucht C; Scherr M; Mustafa M; Leucht S; Ziegler S; Sorg C
Brain; 2019 Jun; 142(6):1813-1826. PubMed ID: 31135051
[TBL] [Abstract][Full Text] [Related]
7. Dopaminergic function in cannabis users and its relationship to cannabis-induced psychotic symptoms.
Bloomfield MA; Morgan CJ; Egerton A; Kapur S; Curran HV; Howes OD
Biol Psychiatry; 2014 Mar; 75(6):470-8. PubMed ID: 23820822
[TBL] [Abstract][Full Text] [Related]
8. Salience attribution and its relationship to cannabis-induced psychotic symptoms.
Bloomfield MA; Mouchlianitis E; Morgan CJ; Freeman TP; Curran HV; Roiser JP; Howes OD
Psychol Med; 2016 Dec; 46(16):3383-3395. PubMed ID: 27628967
[TBL] [Abstract][Full Text] [Related]
9. Reproducibility of PET measurement for presynaptic dopaminergic functions using L-[β-(11)C]DOPA and [(18)F]FE-PE2I in humans.
Suzuki M; Ito H; Kodaka F; Takano H; Kimura Y; Fujiwara H; Sasaki T; Takahata K; Nogami T; Nagashima T; Nengaki N; Kawamura K; Zhang MR; Varrone A; Halldin C; Okubo Y; Suhara T
Nucl Med Commun; 2014 Mar; 35(3):231-7. PubMed ID: 24468851
[TBL] [Abstract][Full Text] [Related]
10. Presynaptic striatal dopamine dysfunction in people at ultra-high risk for psychosis: findings in a second cohort.
Egerton A; Chaddock CA; Winton-Brown TT; Bloomfield MA; Bhattacharyya S; Allen P; McGuire PK; Howes OD
Biol Psychiatry; 2013 Jul; 74(2):106-12. PubMed ID: 23312565
[TBL] [Abstract][Full Text] [Related]
11. Correlation of alcohol craving with striatal dopamine synthesis capacity and D2/3 receptor availability: a combined [18F]DOPA and [18F]DMFP PET study in detoxified alcoholic patients.
Heinz A; Siessmeier T; Wrase J; Buchholz HG; Gründer G; Kumakura Y; Cumming P; Schreckenberger M; Smolka MN; Rösch F; Mann K; Bartenstein P
Am J Psychiatry; 2005 Aug; 162(8):1515-20. PubMed ID: 16055774
[TBL] [Abstract][Full Text] [Related]
12. Defining the Locus of Dopaminergic Dysfunction in Schizophrenia: A Meta-analysis and Test of the Mesolimbic Hypothesis.
McCutcheon R; Beck K; Jauhar S; Howes OD
Schizophr Bull; 2018 Oct; 44(6):1301-1311. PubMed ID: 29301039
[TBL] [Abstract][Full Text] [Related]
13. 18FDG PET in hallucinating and non-hallucinating patients.
Kopecek M; Spaniel F; Novák T; Tislerová B; Belohlávek O; Horácek J
Neuro Endocrinol Lett; 2007 Feb; 28(1):53-9. PubMed ID: 17277726
[TBL] [Abstract][Full Text] [Related]
14. 6-(18)F-DOPA PET study in patients with schizophrenia. Positron emission tomography.
Elkashef AM; Doudet D; Bryant T; Cohen RM; Li SH; Wyatt RJ
Psychiatry Res; 2000 Nov; 100(1):1-11. PubMed ID: 11090720
[TBL] [Abstract][Full Text] [Related]
15. Cortical thickness in individuals with non-clinical and clinical psychotic symptoms.
van Lutterveld R; van den Heuvel MP; Diederen KM; de Weijer AD; Begemann MJ; Brouwer RM; Daalman K; Blom JD; Kahn RS; Sommer IE
Brain; 2014 Oct; 137(Pt 10):2664-9. PubMed ID: 24951640
[TBL] [Abstract][Full Text] [Related]
16. Comparative assessment of 6-[
Becker G; Bahri MA; Michel A; Hustadt F; Garraux G; Luxen A; Lemaire C; Plenevaux A
J Neurochem; 2017 May; 141(4):626-635. PubMed ID: 28294334
[TBL] [Abstract][Full Text] [Related]
17. Striatal dopamine synthesis capacity in twins discordant for schizophrenia.
Shotbolt P; Stokes PR; Owens SF; Toulopoulou T; Picchioni MM; Bose SK; Murray RM; Howes OD
Psychol Med; 2011 Nov; 41(11):2331-8. PubMed ID: 21426628
[TBL] [Abstract][Full Text] [Related]
18. Frontostriatal functional connectivity and striatal dopamine synthesis capacity in schizophrenia in terms of antipsychotic responsiveness: an [
Kim S; Jung WH; Howes OD; Veronese M; Turkheimer FE; Lee YS; Lee JS; Kim E; Kwon JS
Psychol Med; 2019 Nov; 49(15):2533-2542. PubMed ID: 30460891
[TBL] [Abstract][Full Text] [Related]
19. Instrumental measurements of spontaneous dyskinesia and schizotypy in subjects with auditory verbal hallucinations and healthy controls.
Willems AE; Sommer IE; Tenback DE; Koning JP; van Harten PN
Psychiatry Res; 2016 Oct; 244():24-7. PubMed ID: 27455147
[TBL] [Abstract][Full Text] [Related]
20. Glutamatergic and dopaminergic function and the relationship to outcome in people at clinical high risk of psychosis: a multi-modal PET-magnetic resonance brain imaging study.
Howes OD; Bonoldi I; McCutcheon RA; Azis M; Antoniades M; Bossong M; Modinos G; Perez J; Stone JM; Santangelo B; Veronese M; Grace A; Allen P; McGuire PK
Neuropsychopharmacology; 2020 Mar; 45(4):641-648. PubMed ID: 31618752
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
